Nan Shan Life Insurance Co. Ltd. Purchases Shares of 53,900 CME Group Inc. (NASDAQ:CME)

Nan Shan Life Insurance Co. Ltd. purchased a new position in CME Group Inc. (NASDAQ:CMEFree Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 53,900 shares of the financial services provider’s stock, valued at approximately $12,517,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. Czech National Bank increased its position in shares of CME Group by 6.5% during the fourth quarter. Czech National Bank now owns 78,133 shares of the financial services provider’s stock valued at $18,145,000 after purchasing an additional 4,778 shares during the period. Brookstone Capital Management boosted its stake in CME Group by 2.5% during the fourth quarter. Brookstone Capital Management now owns 34,563 shares of the financial services provider’s stock worth $8,026,000 after buying an additional 833 shares in the last quarter. Wedmont Private Capital increased its holdings in CME Group by 11.5% in the 4th quarter. Wedmont Private Capital now owns 2,800 shares of the financial services provider’s stock valued at $642,000 after buying an additional 288 shares during the period. Miracle Mile Advisors LLC lifted its holdings in shares of CME Group by 17.9% during the 4th quarter. Miracle Mile Advisors LLC now owns 4,524 shares of the financial services provider’s stock worth $1,051,000 after acquiring an additional 687 shares during the period. Finally, Pallas Capital Advisors LLC boosted its position in shares of CME Group by 6.4% during the 4th quarter. Pallas Capital Advisors LLC now owns 7,562 shares of the financial services provider’s stock valued at $1,756,000 after acquiring an additional 454 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.8%

CME opened at $268.34 on Wednesday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48. The stock has a market capitalization of $96.70 billion, a PE ratio of 27.75, a PEG ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a 50-day moving average price of $265.08 and a two-hundred day moving average price of $246.25.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the firm earned $2.50 earnings per share. CME Group’s revenue was up 10.4% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.86%. The ex-dividend date is Monday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 50.30%.

Wall Street Analyst Weigh In

A number of brokerages have commented on CME. Oppenheimer raised their price target on shares of CME Group from $269.00 to $279.00 and gave the stock an “outperform” rating in a research note on Friday, April 11th. Keefe, Bruyette & Woods increased their target price on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a report on Thursday, April 24th. Barclays boosted their price target on CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. dropped their price objective on CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a research note on Thursday, April 24th. Finally, Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price on the stock in a research note on Monday, March 10th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $256.80.

View Our Latest Research Report on CME Group

Insider Activity

In other CME Group news, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Dennis Suskind sold 1,000 shares of the company’s stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the sale, the director now owns 2,915 shares of the company’s stock, valued at $790,781.20. The trade was a 25.54% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock valued at $8,975,813 over the last 90 days. 0.30% of the stock is owned by company insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.